|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▲
|
MA Number ▲
|
Registration date ▼
|
Status ▲
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
INFLUENZA VACCINE (SURFACE ANTIGEN, INACTIVATED, PREPARED IN CELL CULTURES) |
J07BB02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006051 |
19-04-2024 |
VALID
|
|
RETIFANLIMAB |
L01FF10 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006194 |
19-04-2024 |
VALID
|
|
SPARSENTAN |
C09XX01 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005783 |
19-04-2024 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
MOMELOTINIB |
L01EJ04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005768 |
25-01-2024 |
VALID
|
|
ADAGRASIB |
L01XX77 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
ROZANOLIXIZUMAB |
L04AG16 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005824 |
05-01-2024 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
PEGZILARGINASE |
A16AB24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005484 |
15-12-2023 |
VALID
|
|
VAMOROLONE |
H02AB18 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005679 |
14-12-2023 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
GADOPICLENOL |
V08CA12 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006172 |
07-12-2023 |
VALID
|
|
ZILUCOPLAN |
L04AJ06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005450 |
01-12-2023 |
VALID
|
|
PALOPEGTERIPARATIDE |
H05AA05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005934 |
17-11-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
TRASTUZUMAB |
L01XC03 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005769 |
15-11-2023 |
VALID
|
|
QUIZARTINIB |
L01EX11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005910 |
06-11-2023 |
VALID
|
|
RITLECITINIB |
L04AF08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006025 |
15-09-2023 |
VALID
|
|
TISLELIZUMAB |
L01FF09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005919 |
15-09-2023 |
VALID
|
|
RESPIRATORY SYNCYTIAL VIRUS VACCINES |
J07BX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006027 |
23-08-2023 |
VALID
|
|
TALQUETAMAB |
L01FX29 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005864 |
21-08-2023 |
VALID
|
|
ATOGEPANT |
N02CD07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
GANAXOLONE |
N03AX27 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005825 |
26-07-2023 |
VALID
|
|
PIFLUFOLASTAT (18F) |
V09IX16 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005520 |
24-07-2023 |
VALID
|
|
GLOFITAMAB |
L01FX28 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005751 |
07-07-2023 |
VALID
|
|
FUTIBATINIB |
L01EN04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005627 |
04-07-2023 |
VALID
|
|
UBLITUXIMAB |
L04AG14 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005914 |
31-05-2023 |
VALID
|
|
MIRIKIZUMAB |
L04AC24 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005122 |
26-05-2023 |
VALID
|
|
IVOSIDENIB |
L01XM02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005936 |
04-05-2023 |
VALID
|
|
PEGUNIGALSIDASE ALFA |
A16AB20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005618 |
04-05-2023 |
VALID
|
|
RUXOLITINIB |
D11AH09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005843 |
19-04-2023 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
ETRANACOGENE DEZAPARVOVEC |
B06XX00 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004827 |
20-02-2023 |
VALID
|
|
TREMELIMUMAB |
L01FX20 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004650 |
20-02-2023 |
VALID
|
|
LONCASTUXIMAB TESIRINE |
L01FX22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005685 |
20-12-2022 |
VALID
|
|
TABELECLEUCEL |
L01XL09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004577 |
16-12-2022 |
VALID
|
|
GALLIUM (68GA) GOZETOTIDE |
V09IX14 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005488 |
09-12-2022 |
VALID
|
|
LUTETIUM (177LU) VIPIVOTIDE TETRAXETAN |
V10XX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005483 |
09-12-2022 |
VALID
|
|
MARALIXIBAT CHLORIDE |
A05AX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005857 |
09-12-2022 |
VALID
|
|
SPESOLIMAB |
L04AC22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005874 |
09-12-2022 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
SUTIMLIMAB |
L04AJ04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005776 |
15-11-2022 |
VALID
|
|
MARIBAVIR |
J05AX10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
MITAPIVAT |
B06AX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005540 |
09-11-2022 |
VALID
|
|
NIRSEVIMAB |
J06BD08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005304 |
31-10-2022 |
VALID
|
|
TEZEPELUMAB |
R03DX11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005588 |
19-09-2022 |
VALID
|